Pelikan
Technologies
combines
novel
and proprietary blood sampling and
measurement techniques with state-of-the-art miniaturization and
automation to develop superior hand-held diagnostic and monitoring
devices. The initial application of the company´s technology is a
next generation electronic lancing device, the Pelikan Sun, designed to
eliminate pain and improve finger health for the diabetes community.
Based on Pelikan´s innovative technology platform, the next generation
of products will be fully integrated, and will streamline
blood glucose monitoring from today's cumbersome, painful, multi-step
process to an automated, one-step process that dramatically improves
ease-of-use, significantly reduces the pain associated with sample
collection, and provides a highly reliable reading.
The company's proprietary technology platform will give rise to the
development of state-of-the-art diagnostic and monitoring devices for a
variety of other medical conditions that involve blood screening and
monitoring. Point-of-care testing and diagnostic panel test systems
also represent markets that can greatly benefit from this novel
technology.
To download our technology whitepaper “Clinical Rationale for
Electronic Lancing”, please click here.